| 351 | XGNExagen Inc. |
$66.6M |
-30.0% |
2025 |
| 352 | ENTAEnanta Pharmaceuticals Inc |
$65.3M |
-125.4% |
2025 |
| 353 | FBIOPFortress Biotech, Inc. |
$63.3M |
10.8% |
2025 |
| 354 | NUVBNuvation Bio Inc. |
$62.9M |
-325.3% |
2025 |
| 355 | TNGXTango Therapeutics, Inc. |
$62.4M |
-162.9% |
2025 |
| 356 | DERMJourney Medical Corp |
$61.9M |
-18.5% |
2025 |
| 357 | CSBRChampions Oncology, Inc. |
$59.4M |
-2.0% |
2026 |
| 358 | APTAlpha Pro Tech Ltd |
$59.1M |
6.0% |
2025 |
| 359 | LNSRLENSAR, Inc. |
$58.4M |
-58.7% |
2025 |
| 360 | CVRXCVRx, Inc. |
$56.7M |
-94.1% |
2025 |
| 361 | NKTRNektar Therapeutics |
$55.2M |
-297.1% |
2025 |
| 362 | AGIOAgios Pharmaceuticals, Inc. |
$54M |
-764.0% |
2025 |
| 363 | QTTBQ32 Bio Inc. |
$53.7M |
55.5% |
2025 |
| 364 | IVVDInvivyd, Inc. |
$53.4M |
-98.2% |
2025 |
| 365 | APYXApyx Medical Corp |
$52.8M |
-21.2% |
2025 |
| 366 | PLXProtalix BioTherapeutics, Inc. |
$52.7M |
-12.5% |
2025 |
| 367 | OCULOcular Therapeutix, Inc |
$52M |
-511.9% |
2025 |
| 368 | CARLCarlsmed, Inc. |
$50.5M |
-58.7% |
2025 |
| 369 | LXRXLexicon Pharmaceuticals, Inc. |
$49.8M |
-101.1% |
2025 |
| 370 | GOSSGossamer Bio, Inc. |
$48.5M |
-351.5% |
2025 |
| 371 | SIShoulder Innovations, Inc. |
$47.3M |
-85.3% |
2025 |
| 372 | PTGXProtagonist Therapeutics, Inc |
$46M |
-282.8% |
2025 |
| 373 | SEPNSepterna, Inc. |
$46M |
-106.4% |
2025 |
| 374 | TLSITriSalus Life Sciences, Inc. |
$45.2M |
-86.9% |
2025 |
| 375 | FENCFennec Pharmaceuticals Inc. |
$44.6M |
-21.8% |
2025 |
| 376 | AQSTAquestive Therapeutics, Inc. |
$44.5M |
-188.1% |
2025 |
| 377 | CPIXCumberland Pharmaceuticals Inc |
$44.5M |
-6.4% |
2025 |
| 378 | SNWVSANUWAVE Health, Inc. |
$44.1M |
26.8% |
2025 |
| 379 | XLOXilio Therapeutics, Inc. |
$43.8M |
-80.1% |
2025 |
| 380 | WVEWave Life Sciences Ltd. |
$42.7M |
-478.3% |
2025 |
| 381 | SSIISS Innovations International, Inc. |
$42.5M |
-28.5% |
2025 |
| 382 | CHRSCoherus Oncology, Inc. |
$42.2M |
398.4% |
2025 |
| 383 | KRMDKORU Medical Systems, Inc. |
$41.1M |
-6.4% |
2025 |
| 384 | MYOMyomo, Inc. |
$40.9M |
-38.1% |
2025 |
| 385 | EDITEditas Medicine, Inc. |
$40.5M |
-395.0% |
2025 |
| 386 | TKNOAlpha Teknova, Inc. |
$40.5M |
-42.6% |
2025 |
| 387 | VYGRVoyager Therapeutics, Inc. |
$40.4M |
-296.5% |
2025 |
| 388 | KYMRKymera Therapeutics, Inc. |
$39.2M |
-794.0% |
2025 |
| 389 | UTMDUtah Medical Products Inc |
$38.5M |
29.3% |
2025 |
| 390 | BGMBGM Group Ltd. |
$37.9M |
-52.6% |
2025 |
| 391 | CLPTClearPoint Neuro, Inc. |
$37M |
-69.1% |
2025 |
| 392 | CCCCC4 Therapeutics, Inc. |
$35.9M |
-292.1% |
2025 |
| 393 | VRCAVerrica Pharmaceuticals Inc. |
$35.6M |
-50.3% |
2025 |
| 394 | SENSSenseonics Holdings, Inc. |
$35.3M |
-196.0% |
2025 |
| 395 | XFORX4 Pharmaceuticals, Inc |
$35.1M |
-225.6% |
2025 |
| 396 | BHSTBioharvest Sciences Inc. |
$34.5M |
-32.3% |
2025 |
| 397 | DTILPrecision Biosciences Inc |
$34.3M |
-133.4% |
2025 |
| 398 | OBIOOrchestra BioMed Holdings, Inc. |
$33.5M |
-157.4% |
2025 |
| 399 | MXCTMaxcyte, Inc. |
$33M |
-135.1% |
2025 |
| 400 | STXSStereotaxis, Inc. |
$32.4M |
-66.8% |
2025 |